Skip to main content
Clinical Trials/NCT04545502
NCT04545502
Recruiting
Not Applicable

A Prospective and Retrospective, Multi-Centre, Post-Market, Non-Interventional Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches

Vascutek Ltd.31 sites in 7 countries2,000 target enrollmentFebruary 17, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aneurysm
Sponsor
Vascutek Ltd.
Enrollment
2000
Locations
31
Primary Endpoint
Operative Death
Status
Recruiting
Last Updated
11 months ago

Overview

Brief Summary

The purpose of this registry is to collect safety and performance data on all commercially available Terumo Aortic knitted and woven grafts, and cardiovascular patches in standard clinical practice.

Data will be collected both retrospectively and prospectively.

Registry
clinicaltrials.gov
Start Date
February 17, 2021
End Date
January 2037
Last Updated
11 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Vascutek Ltd.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients must meet all of the following inclusion criteria in order to be eligible for inclusion in the study:
  • All Patients:
  • Patient meets the minimum age as per local regulations at time of consent
  • Patient requires treatment with study device(s) according to the IFU(s)
  • Patient is willing and able to comply with all SOC procedures and study visits
  • Patient or their legally authorised representative (LAR) has given written informed consent to participate in study, including consent to collect data retrospectively
  • For prospective emergency patients, retrospective consent is permissible
  • For retrospective patients who are deceased at time of enrollment, local EC regulations relating to consent process should be followed.
  • Retrospective Patients only:
  • Patient has a minimum of 1 year post-operative follow-up data available, or complete data to death.

Exclusion Criteria

  • Any patient who meets any of the following exclusion criteria will be excluded from participation in the study:
  • Patient is unable or unwilling to comply with the SOC procedures or follow-up regime
  • Patient is contraindicated per the device IFU
  • Patient has any other medical, social or psychological problems that in the opinion of the investigator preclude them from receiving this treatment and the procedures and evaluations pre- and post-procedure

Outcomes

Primary Outcomes

Operative Death

Time Frame: 1 Year

30 Day or In-Hospital Mortality

Graft Leakage

Time Frame: 1 Year

Device Failure: The presence of leakage or excessive bleeding through graft/patch

Secondary Outcomes

  • Procedural Endpoints(1 Year)
  • Safety Endpoints(1 Year)
  • Device Endpoints(1 Year)

Study Sites (31)

Loading locations...

Similar Trials